Skip to main content
. Author manuscript; available in PMC: 2014 Nov 15.
Published in final edited form as: Clin Cancer Res. 2013 Sep 27;19(22):10.1158/1078-0432.CCR-13-1975. doi: 10.1158/1078-0432.CCR-13-1975

Table 1. SCLC cell lines: mutational status and IC50 values.

BMN 673 and cisplatin IC50 values calculated from proliferation assays. Mutational status of SCLC cell lines tested for TP53, RB1 and myc amplification (mt = mutant, wt = wild type, unk = unknown) are shown.

Cell Line TP53 RB1 myc
amp.
BMN 673
IC50 (nM)
Cisplatin
IC50 (nM)
H209* mt mt none 1.7 45.5
H1048 mt mt none 2.2 1087
H524* mt mt myc 3.1 976
H1930* mt wt none 4.1 153
H69* mt mt n-myc 5.2 2723
H2081 wt mt none 6.3 2669
H2107* mt mt l-myc 7.3 811
H1092* mt wt l-myc 8.9 1611
DMS-79* mt mt none 9.3 1189
H446* mt mt myc 13 2074
COR-L279 mt mt unk 15 620
*

Protein profile included in proteomic analysis